These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9593595)

  • 21. In vivo chronic carvedilol treatment in rats attenuates ex vivo regional infarction of the heart.
    Starkopf J; Hegna S; Johansen OE; Munch-Ellingsen J; Mjøs OD; Ytrehus K
    Scand Cardiovasc J; 2006 Aug; 40(4):240-7. PubMed ID: 16914417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carvedilol: a nonselective beta blocking agent with antioxidant properties.
    Book WM
    Congest Heart Fail; 2002; 8(3):173-7, 190. PubMed ID: 12045386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
    Feuerstein GZ; Ruffolo RR
    Eur Heart J; 1996 Apr; 17 Suppl B():24-9. PubMed ID: 8733068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability.
    Cargnoni A; Ceconi C; Bernocchi P; Boraso A; Parrinello G; Curello S; Ferrari R
    Cardiovasc Res; 2000 Aug; 47(3):556-66. PubMed ID: 10963728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hydroxylated analog of the beta-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts.
    Kramer JH; Weglicki WB
    Free Radic Biol Med; 1996; 21(6):813-25. PubMed ID: 8902527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis.
    Yue-Chun L; Teng Z; Na-Dan Z; Li-Sha G; Qin L; Xue-Qiang G; Jia-Feng L
    PLoS One; 2012; 7(6):e39394. PubMed ID: 22761780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
    Ferrer I; Friguls B; Dalfó E; Planas AM
    Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cardioprotective effects of carvedilol on ischemia and reperfusion injury by AMPK signaling pathway.
    Hu H; Li X; Ren D; Tan Y; Chen J; Yang L; Chen R; Li J; Zhu P
    Biomed Pharmacother; 2019 Sep; 117():109106. PubMed ID: 31200253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carvedilol: just another Beta-blocker or a powerful cardioprotector?
    Carreira RS; Monteiro P; Gon Alves LM; Providência LA
    Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):257-66. PubMed ID: 17378771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carvedilol versus metoprolol in the acute phase of myocardial infarction:
    Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S222-6. PubMed ID: 15683501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of beta-adrenoceptor blockade on the myocardial accumulation of fatty acid tracer and its intracellular metabolism in the heart after ischemia-reperfusion injury.
    Igarashi N; Nozawa T; Fujii N; Suzuki T; Matsuki A; Nakadate T; Igawa A; Inoue H
    Circ J; 2006 Nov; 70(11):1509-14. PubMed ID: 17062979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of carvedilol on atrioventricular conduction in the ischemic heart.
    Horio T; Ito S; Aoyama M; Takeda Y; Suzumura H; Nakata K; Yamada Y; Suzuki S; Fukutomi T; Itoh M
    Eur J Pharmacol; 2001 Jan; 412(2):145-53. PubMed ID: 11165226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.
    Liu HT; Zhang HF; Si R; Zhang QJ; Zhang KR; Guo WY; Wang HC; Gao F
    Sheng Li Xue Bao; 2007 Oct; 59(5):651-9. PubMed ID: 17940706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.
    Dunn CJ; Lea AP; Wagstaff AJ
    Drugs; 1997 Jul; 54(1):161-85. PubMed ID: 9211087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of carvedilol on cardiomyocyte apoptosis and gene expression in vivo after ischemia-reperfusion in rats.
    Zeng H; Liu X; Zhao H
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):127-30. PubMed ID: 12973927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carvedilol decreases elevated oxidative stress in human failing myocardium.
    Nakamura K; Kusano K; Nakamura Y; Kakishita M; Ohta K; Nagase S; Yamamoto M; Miyaji K; Saito H; Morita H; Emori T; Matsubara H; Toyokuni S; Ohe T
    Circulation; 2002 Jun; 105(24):2867-71. PubMed ID: 12070115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carvedilol retards sudden loss of contraction during early regional myocardial ischemia in feline hearts.
    Brunvand H; Grong K
    J Pharmacol Exp Ther; 1997 Jul; 282(1):363-8. PubMed ID: 9223575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of carvedilol on left ventricular function and arrhythmias during repeated short-time myocardial ischemia in experimental pigs.
    Höher M; Friedrich M; Sommer T; Marten A; Ehmer B; Hombach V; Hirche H
    Z Kardiol; 1989; 78 Suppl 3():7-15. PubMed ID: 2573214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of carvedilol on ryanodine receptor in heart failure].
    Li R; Yi QJ; Qian YR; Liu XY
    Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):603-7. PubMed ID: 16191273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nonselective beta-blocker carvedilol suppresses apoptosis in human cardiac tissue: a pilot study.
    Usta E; Mustafi M; Straub A; Ziemer G
    Heart Surg Forum; 2010 Aug; 13(4):E218-22. PubMed ID: 20719722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.